Distribution of the phosphodiesterase isoenzymes PDE1, PDE2 and PDE5 in different blood vessels

被引：0
|
作者：
Mergia, E [1 ]
Koesling, D [1 ]
机构：
[1] Ruhr Univ Bochum, Inst Pharmakol & Toxikol, D-44780 Bochum, Germany
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 2004年 / 369卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
216
引用
收藏
页码：R54 / R54
页数：1
相关论文
共 50 条
  • [1] The effect of PDE1, PDE2, PDE5 selective and non-selective phosphodiesterase inhibitors on peristalsis in the guinea-pig isolated ileum
    Tuladhar, BR
    Cooper, N
    Naylor, RJ
    BRITISH JOURNAL OF PHARMACOLOGY, 1998, 124 : U52 - U52
  • [2] Activation of PDE2 and PDE5 by specific GAF ligands: delayed activation of PDE5
    Jaeger, Ronald
    Schwede, Frank
    Genieser, Hans-Gottfried
    Koesling, Doris
    Russwurm, Michael
    BRITISH JOURNAL OF PHARMACOLOGY, 2010, 161 (07) : 1645 - 1660
  • [3] Implication of cGMP cyclic nucleotide phosphodiesterases PDE1, PDE2 and PDE5 in early angiotensin II induced cardiac hypertrophy in rat
    Mokni, Walid
    Keravis, Therese
    Schini-Kerth, Valerie
    Lugnier, Claire
    FASEB JOURNAL, 2011, 25
  • [4] Optimization of purine based PDE1/PDE5 inhibitors to a potent and selective PDE5 inhibitor for the treatment of male ED
    Boyle, CD
    Xu, R
    Asberom, T
    Chackalamannil, S
    Clader, JW
    Greenlee, WJ
    Guzik, H
    Hu, YQ
    Hu, ZY
    Lankin, CM
    Pissarnitski, DA
    Stamford, AW
    Wang, YG
    Skell, J
    Kurowski, S
    Vemulapalli, S
    Palamanda, J
    Chintala, M
    Wu, P
    Myers, J
    Wang, P
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (09) : 2365 - 2369
  • [5] Inhibitors of PDE1 and PDE5 cGMP phosphodiesterases: Patents and therapeutic potential
    Sybertz, E
    Czarniecki, M
    EXPERT OPINION ON THERAPEUTIC PATENTS, 1997, 7 (06) : 631 - 639
  • [6] Inhibition of PDE2, PDE5 and PDE10: Effects on short-term memory
    Reneerkens, O. A. H.
    Rutten, K.
    Sik, A.
    Blokland, A.
    Steckler, T.
    Steinbusch, H. W. M.
    Prickaerts, J.
    BEHAVIOURAL PHARMACOLOGY, 2008, 19 (5-6): : 670 - 670
  • [7] PDE2 and PDE10, but not PDE5, inhibition affect basic auditory information processing in rats
    Reneerkens, O. A. H.
    Sambeth, A.
    Blokland, A.
    Prickaerts, J.
    BEHAVIOURAL BRAIN RESEARCH, 2013, 250 : 251 - 256
  • [8] Inhibition of PDE2 and PDE5: Effects on object recognition and object location memory
    Reneerkens, O. A. H.
    Rutten, K.
    Sik, A.
    Steinbusch, H. W. M.
    Blokland, A.
    Prickaerts, J.
    BEHAVIOURAL PHARMACOLOGY, 2007, 18 : S100 - S100
  • [9] Synthesis and evaluation of polycyclic pyrazolo[3,4-d]pyrimidines as PDE1 and PDE5 cGMP phosphodiesterase inhibitors
    Xia, Y
    Chackalamannil, S
    Czarniecki, M
    Tsai, HG
    Vaccaro, H
    Cleven, R
    Cook, J
    Fawzi, A
    Watkins, R
    Zhang, HT
    JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (26) : 4372 - 4377
  • [10] Conversion of phosphodiesterase-5 (PDE5) catalytic site to higher affinity by PDE5 inhibitors
    Blount, Mitsi A.
    Zoraghi, Roya
    Bessay, Emmanuel P.
    Beasley, Alfreda
    Francis, Sharron H.
    Corbin, Jackie D.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2007, 323 (02): : 730 - 737
12345